INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 195 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $433,359 | -29.5% | 32,268 | -35.1% | 0.02% | -51.4% |
| Q4 2022 | $614,727 | -12.6% | 49,695 | -1.4% | 0.04% | -15.9% |
| Q3 2022 | $703,000 | +244.6% | 50,390 | +302.5% | 0.04% | +388.9% |
| Q4 2021 | $204,000 | -26.1% | 12,520 | -32.7% | 0.01% | -43.8% |
| Q3 2021 | $276,000 | +25.5% | 18,613 | +69.1% | 0.02% | +14.3% |
| Q2 2021 | $220,000 | -48.8% | 11,010 | -40.8% | 0.01% | -33.3% |
| Q1 2021 | $430,000 | -68.7% | 18,610 | -66.5% | 0.02% | -65.0% |
| Q4 2020 | $1,373,000 | -16.3% | 55,590 | +40.5% | 0.06% | -22.1% |
| Q3 2020 | $1,641,000 | +11.3% | 39,570 | +28.6% | 0.08% | +2.7% |
| Q2 2020 | $1,474,000 | +0.5% | 30,775 | +32.1% | 0.08% | -29.2% |
| Q1 2020 | $1,467,000 | +439.3% | 23,299 | +1971.0% | 0.11% | +292.6% |
| Q2 2015 | $272,000 | – | 1,125 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |